Ani pharmaceuticals, inc. announces positive clinical results from cortrophin gel cortisol response study

Ani pharmaceuticals, inc. announced the receipt of clinical data on cortrophin gel (80 units/ml) from a study that evaluated the blood-level cortisol response in a 20-person healthy volunteer population. key results: the results indicate that ani's cortrophin gel (80 units/ml) is effective for its intended use; in addition, the clinical data demonstrate that ani's modernized cortrophin gel (80 units/ml) drug product has a cortisol response profile consistent with that observed in historical scientific literature that evaluated cortrophin gel (44 units/ml) drug product manufactured in the 1960s (brombacher et. al, 1969); no adverse safety events to be reported and minor events were as expected.
ANIP Ratings Summary
ANIP Quant Ranking